The emerging approach of the medication represents a major advance in the handling of the condition. Unlike existing drugs, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and GIP – providing https://tirzepatide-peptide144398.kylieblog.com/42554087/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment